Kibow Therapeutics
PrivateLast Round
Series A
May 17, 2022
Total Funding Raised
$2.53M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kibow Therapeutics is a biotechnology company that develops live biotherapeutic products for the treatment of chronic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, D2C Brands, Drug Discovery
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kibow Therapeutics Comparables
Compare Kibow Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notitia Biotechnologies | 71% | |
| Sanzyme Private Limited | 70% | |
| Rasa Industries, Ltd. | 61% | |
Kibow Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 17, 2022 | ||||
| Grant | Dec 15, 2003 | ||||
| Grant | Jan 1, 2002 |
Kibow Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 1786% MoM, reaching 1.5K.
- May 17, 2022
$50M round completed.
Kibow Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kibow Therapeutics's valuation, stock price, and market status.